QSI
Quantum-Si incorporated
$1.06
+0.07
(+7.07%)
Mkt Cap
209.69M
Volume
8,784,965
52W Range
0.691-3.1
Sector
Healthcare
Beta
3.16
EPS (TTM)
-0.51
P/E Ratio
-2.15
Revenue (TTM)
1.85M
Rev Growth (5Y)
N/A
EPS Growth (5Y)
N/A
Company Description
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.44M | 3.06M | 1.08M | 0 | 0 | 0 | 0 |
| Net Income | (101.34M) | (101.01M) | (95.96M) | (132.44M) | (94.99M) | (36.61M) | (35.80M) |
| EPS | -0.51 | -0.71 | -0.68 | -0.95 | -1.19 | -6.81 | -0.26 |
| Free Cash Flow | (97.23M) | (92.38M) | (99.31M) | (101.30M) | (72.58M) | (33.03M) | (31.95M) |
| FCF / Share | -0.49 | -0.65 | -0.70 | -0.73 | -0.91 | -6.14 | -0.23 |
| Operating CF | (94.72M) | (87.80M) | (94.04M) | (90.56M) | (66.81M) | (32.57M) | (30.71M) |
| Total Assets | 245.61M | 247.87M | 298.25M | 391.49M | 503.23M | 40.59M | 37.41M |
| Total Debt | 4.17M | 12.95M | 15.30M | 17.45M | 8.08M | 1.75M | 0 |
| Cash & Equiv | 21.64M | 49.24M | 133.86M | 84.32M | 35.78M | 36.91M | 32.93M |
| Book Value | 220.23M | 215.42M | 271.62M | 358.71M | 477.03M | 36.09M | 35.46M |
| Return on Equity | -0.46 | -0.47 | -0.35 | -0.37 | -0.20 | -1.01 | -1.01 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 258,000 | 451,000 | 552,000 | 591,000 | 842,000 | 1.19M | 787,000 | 622,000 | 457,000 | 400,000 | 223,000 | 205,000 |
| Net Income | (21.67M) | (17.61M) | (35.70M) | (28.84M) | (19.19M) | (33.12M) | (25.31M) | (23.10M) | (19.47M) | (22.05M) | (24.73M) | (25.57M) |
| EPS | -0.10 | -0.08 | -0.17 | -0.16 | -0.11 | -0.23 | -0.18 | -0.16 | -0.14 | -0.16 | -0.17 | -0.18 |
| Free Cash Flow | (25.92M) | (16.33M) | (32.92M) | (20.52M) | (27.46M) | (24.32M) | (24.13M) | (19.68M) | (24.31M) | (20.60M) | (22.82M) | (23.73M) |
| FCF / Share | -0.12 | -0.08 | -0.16 | -0.11 | -0.15 | -0.17 | -0.17 | -0.14 | -0.17 | -0.15 | -0.16 | -0.17 |
| Operating CF | (25.64M) | (16.35M) | (32.02M) | (20.20M) | (26.15M) | (22.88M) | (23.15M) | (18.55M) | (23.21M) | (20.97M) | (21.44M) | (22.93M) |
| Total Assets | 213.35M | 245.61M | 260.13M | 254.41M | 271.22M | 247.87M | 236.45M | 256.75M | 275.58M | 298.25M | 318.10M | 341.17M |
| Total Debt | 3.71M | 4.17M | 4.61M | 11.14M | 12.05M | 12.95M | 13.82M | 13.65M | 14.48M | 15.30M | 15.45M | 16.21M |
| Cash & Equiv | 36.20M | 21.64M | 30.91M | 22.19M | 37.29M | 49.24M | 42.27M | 59.55M | 53.16M | 133.86M | 93.82M | 87.93M |
| Book Value | 200.74M | 220.23M | 235.16M | 220.98M | 246.92M | 215.42M | 210.52M | 233.26M | 253.77M | 271.62M | 292.06M | 315.30M |
| Return on Equity | -0.11 | -0.08 | -0.15 | -0.13 | -0.08 | -0.15 | -0.12 | -0.10 | -0.08 | -0.08 | -0.08 | -0.08 |
QSI News
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si Q1 Earnings Call Highlights
Quantum-Si Incorporated (QSI) Reports Q1 Loss, Misses Revenue Estimates
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments
Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard
Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026